Global Bioprocess Bags Market Outlook, 2031

2026

Global Bioprocess Bags Market Outlook, 2031

The Global Bioprocess Bags Market is segmented into By Product Type (3D Bags, 2D Bags, Other Bags & Accessories); By Workflow (Upstream Processing, Downstream Processing, Process Development); By End-User (Biopharmaceutical Companies, CMOs/CDMOs, Academic & Research Institutes).

Bonafide Research
31-07-2026
Pages : 190
Figures : 36
Tables : 86
Region : Global
Category : Lifescience & Healthcare
Biotechnology

Schedule a Call
Sikandar Kesari — Research Analyst

Buy Now Get Free sample

The Global Bioprocess Bags Market was valued at more than USD 4.67 Billion in 2025 with the CAGR of 16.16% from 2026-2031.

Historical Period2020-2024
Base Year2025
Forecast Period2026-2031
Market Size (2025) USD 4.67 Billion
Market Size (2031) USD 11.22 Billion
CAGR (2026-2031) 16.16%
Largest MarketNorth America
Fastest Market Asia-Pacific
Format

Featured Companies

1. Parker Hannifin Corp (Parker Lord)
2. Corning Incorporated
3. Lonza Group AG
4. Danaher Corporation
5. DCL Corporation
6. Thermo Fisher Scientific Inc
7. Sartorius AG
8. Meissner Filtration Products Inc.
9. Tofflon Science and Technology Group Co., Ltd.
More...

Bioprocess Bags Market Grows with Increasing Adoption of Single-Use Bioprocessing Technologies and Rising Biopharmaceutical Manufacturing Demand.

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

Bioprocess Bags Market Analysis

The global bioprocess bags market encompasses single-use, medical-grade polymeric fluid handling containers engineered specifically for the sterile processing, intermediate storage, and transport of critical biological liquids, including cell cultures, growth media, buffer solutions, and active pharmaceutical ingredients. As modern biomanufacturing continually shifts away from traditional, rigid stainless-steel infrastructure, these flexible 2D and 3D containment systems have established paramount relevance within biopharmaceutical operations. Their primary importance stems from their ability to eliminate cross-contamination risks between production runs, drastically shorten batch turnaround times, and bypass capital-intensive cleaning and sterilization validation procedures. Consequently, bioprocess bags offer biopharma facilities reduced energy and water consumption alongside lower overall operational expenditures. Market expansion is vigorously propelled by key growth drivers, including the rapid pipeline growth of biologics, monoclonal antibodies, biosimilars, vaccines, and advanced personalized cell and gene therapies. Furthermore, the booming reliance on Contract Development and Manufacturing Organizations (CDMOs) that demand scalable, highly adaptable, and multi-product production platforms significantly fuels market momentum. Recent innovations such as tough multilayer barrier films with low gas transmission rates and AI-powered smart sensors for real-time pH, temperature, and pressure tracking further amplify their operational utility. Industry standards, safety protocols, and commercialization pathways are heavily shaped by key trade associations, most notably the Bio-Process Systems Alliance (BPSA). The BPSA actively works to drive standardization in single-use bioprocessing, establishing rigorous guidelines for extractables and leachables (E&L) testing, developing risk-assessment frameworks, formulating recycling and sustainability directives, and engaging with regulatory bodies like the FDA and EMA. Through these essential collective activities, the bioprocess bags ecosystem maintains strict quality control, enhances supply chain robustness, and facilitates the accelerated commercialization of life-saving biotherapeutics globally. According to the research report "Global Bioprocess Bags Market Outlook, 2031," published by Bonafide Research, the Global Bioprocess Bags Market was valued at more than USD 4.67 Billion in 2025, and expected to reach a market size of more than USD 11.22 Billion by 2031 with the CAGR of 16.16% from 2026-2031. . Essential for reducing cross-contamination risk, eliminating costly clean-in-place (CIP) validation, and dramatically shortening batch turnaround times, single-use containment systems dominate biological fluid handling, with 2D bioprocess bags currently commanding nearly 50% of total market revenue. Leading global companies driving commercial innovation include Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Entegris, and SaniSure. Recent strategic developments underscore rapid technological progress: SaniSure introduced its Fill4Sure custom single-use filling assembly to streamline drug product filling, Entegris commercialized high-performance Aramus 2D fluoropolymer bags engineered for extreme cold-chain storage and high chemical purity, and Sartorius completed a €2.4 billion acquisition of Polyplus to significantly strengthen its single-use cell and gene therapy portfolio. Substantial commercial opportunities are emerging in customized, ultra-pure bag configurations tailored for viral-vector gene therapies, integration of AI-powered smart optical sensors for continuous real-time pH and dissolved oxygen tracking, and the development of sustainable, recyclable polyolefin materials. From a supply chain perspective, the market depends on a tightly integrated, multi-tier ecosystem encompassing medical-grade resin suppliers (polyethylene, EVA, and fluoropolymers), film extruders, specialized fitting and tubing fabricators, cleanroom assemblers, and specialized gamma-irradiation sterilization facilities. Because drug production mandates absolute sterility and low extractable/leachable profiles, supply chain vulnerabilities such as resin shortages or sterilization capacity constraints can severely trigger biomanufacturing bottlenecks.

to Download this information in a PDF

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Dynamics

Market Drivers•  Proliferation of biologics, cell & gene therapies (CGTs), and vaccines:  The global drug pipeline is increasingly dominated by advanced biotherapeutics, such as monoclonal antibodies (mAbs), recombinant proteins, messenger RNA (mRNA) vaccines, and personalized cell and gene therapies. These high-value, shear-sensitive therapies require precise, highly sterile, and specialized fluid handling platforms throughout upstream cell culture, harvesting, downstream purification, and low-temperature cryopreservation workflows. Because autologous and allogeneic cell therapies operate on small, patient-specific batch sizes, multi-layer 2D and 3D bioprocess bags provide the scalable micro-environment necessary to handle irreplaceable biological payloads without risking yield loss.
•  Operational flexibility:  Biopharmaceutical manufacturing is undergoing a structural transition from traditional stainless-steel bioreactor infrastructure to single-use flexible systems. Bioprocess bags eliminate complex Clean-in-Place (CIP) and Steam-in-Place (SIP) validation steps, substantially reducing turnaround times between production batches. By removing the need for high-volume water-for-injection (WFI) cleaning and sterilizing chemicals, single-use bags lower capital expenditures and operational expenses while mitigating cross-contamination risks across multi-product manufacturing facilities. This agility is vital for Contract Development and Manufacturing Organizations (CDMOs) that must rapidly pivot between client campaigns without risking batch integrity.

Market Challenges•  Plastic waste accumulation:  The rapid widespread adoption of single-use bioprocessing containers has generated substantial volumes of solid plastic waste. Multi-layer films are challenging to recycle via conventional mechanical methods because the individual polymer layers cannot be easily separated. Most spent bioprocess bags end up in hazardous medical waste streams designated for high-energy incineration or landfilling. As biopharmaceutical operators face escalating environmental, social, and governance (ESG) scrutiny, strict regional decarbonization targets make the disposal of single-use polymers a major operational hurdle, forcing suppliers to innovate sustainable disposal and recycling channels.
•  Stringent compliance validation:  Because bioprocess bags are composed of complex polymeric films such as polyethylene (PE), ethylene vinyl acetate (EVA), and fluoropolymers there is a constant risk that volatile or semi-volatile chemical compounds could migrate into sensitive cell culture media, buffer solutions, or final drug formulations. These leachables can alter biological product stability, cause cellular toxicity, or induce immunogenic reactions in end patients. Navigating strict safety mandates from regulatory bodies (such as the FDA and EMA) requires biopharma firms to conduct extensive, costly, and time-consuming extractables and leachables characterization studies, creating significant deployment delays and increasing total cost of ownership.

Market Trends•  Smart optical sensors:  Modern bioprocess bags are transitioning from static storage containers into dynamic, smart single-use bio-reactors. Leading manufacturers are embedding non-invasive, pre-sterilized Process Analytical Technology (PAT) sensors directly into bag assemblies. These smart sensors allow continuous, real-time monitoring of critical process parameters such as pH, dissolved oxygen ($DO$), temperature, and hydrostatic pressure without breaching system sterility or requiring manual aseptic sampling. This real-time telemetry integrates directly with automated supervisory control and data acquisition (SCADA) platforms to maintain target cell growth conditions and streamline continuous biomanufacturing workflows.
•  Emergence of advanced polymeric films:  To simultaneously resolve E&L concerns and meet corporate sustainability goals, film chemistry is rapidly evolving. Material suppliers are commercializing specialized, ultra-purity fluoropolymer films (such as expanded PTFE or fluorinated ethylene propylene) that deliver near-zero leachables profiles alongside gas-barrier properties for deep sub-zero cryopreservation. Concurrently, key industry players are introducing bio-allocated and recyclable polyolefin film resins derived from renewable feedstock. These next-generation bio-films significantly reduce greenhouse gas footprints during manufacturing while preserving biocompatibility and chemical resistance required for biological handling.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Bioprocess Bags Segmentation

By Product Type	3D Bags
	2D Bags
	Other Bags & Accessories
By Workflow	Upstream Processing
	Downstream Processing
	Process Development
By End-User	Biopharmaceutical Companies
	CMOs/CDMOs
	Academic & Research Institutes
Geography	North America	United States
		Canada
		Mexico
	Europe	Germany
		United Kingdom
		France
		Italy
		Spain
		Russia
	Asia-Pacific	China
		Japan
		India
		Australia
		South Korea
	South America	Brazil
		Argentina
		Colombia
	MEA	United Arab Emirates
		Saudi Arabia
		South Africa

3D bioprocess bags are the largest and fastest-growing product type because they provide efficient, sterile, high-volume fluid management that meets the operational requirements of modern biopharmaceutical manufacturing. 3D bioprocess bags have become the preferred product type because they address the practical challenges associated with handling large quantities of biological fluids throughout commercial-scale manufacturing. Their three-dimensional structure allows them to fit into rigid support containers, providing stability while maximizing storage and processing capacity compared with flat bag designs. They are extensively used for media storage, buffer preparation, intermediate product holding, harvest collection, and bulk drug substance storage, making them applicable across numerous manufacturing stages. Their disposable nature eliminates the need for cleaning, sterilization, and cleaning validation required for stainless-steel systems, reducing operational complexity and minimizing downtime between production batches. Manufacturers producing monoclonal antibodies, recombinant proteins, vaccines, cell therapies, and gene therapies increasingly depend on these bags because they help maintain sterile closed systems that reduce opportunities for microbial contamination and product loss. Advanced multilayer film technologies provide mechanical durability, chemical compatibility, and protection against gas transmission while maintaining the integrity of sensitive biological materials. Modern 3D bags are supplied with integrated tubing, aseptic connectors, sampling ports, and compatibility with automated monitoring systems, allowing seamless incorporation into single-use production platforms. They also support manufacturing flexibility by enabling facilities to process multiple products without extensive equipment modifications. Their availability in numerous volume capacities allows organizations to use standardized disposable systems from process development through commercial manufacturing. In addition, the reduced demand for water, steam, and cleaning chemicals aligns with facility sustainability initiatives while lowering utility requirements. Upstream processing is the largest workflow segment because it requires extensive use of bioprocess bags for sterile media preparation, cell culture support, and fluid handling throughout the earliest stages of biologics production. Upstream processing represents the foundation of biopharmaceutical manufacturing because it includes media preparation, buffer preparation, inoculum expansion, seed train development, cell cultivation, and fermentation activities that determine the productivity and quality of the final biological product. Bioprocess bags are used extensively during these operations to maintain sterile environments while storing and transferring culture media, nutrients, process solutions, and harvested cell suspensions. Since living cells are highly sensitive to contamination, maintaining closed processing systems is essential, and disposable bags significantly reduce exposure to external contaminants during fluid handling. They are commonly connected with single-use mixers, bioreactors, filtration systems, and transfer assemblies, enabling efficient movement of materials without interrupting aseptic conditions. The increasing production of monoclonal antibodies, recombinant proteins, viral vectors, vaccines, and advanced cell-based therapies has strengthened reliance on upstream single-use technologies because these products require carefully controlled cultivation environments. Disposable bioprocess bags also simplify process setup by eliminating equipment cleaning and sterilization requirements before production begins, allowing facilities to prepare new batches more efficiently. Their flexibility supports both small-scale research operations and commercial manufacturing without requiring extensive modifications to production infrastructure. Manufacturers benefit from standardized bag assemblies that improve consistency while reducing operational complexity across multiple production campaigns. Furthermore, upstream operations often involve frequent media exchanges, nutrient additions, and process sampling, all of which are facilitated by integrated ports and sterile tubing systems incorporated into modern bioprocess bags. As biopharmaceutical companies continue emphasizing flexible manufacturing, contamination control, process efficiency, and rapid product changeovers, upstream processing remains the workflow where disposable bioprocess bags provide the broadest operational value and highest level of routine utilization. Biopharmaceutical companies represent the largest end-user segment because they conduct extensive biologics manufacturing operations that require reliable, sterile, and flexible single-use fluid management systems throughout production. Biopharmaceutical companies are the primary users of bioprocess bags because they perform every stage of biologic drug development and commercial manufacturing, from research-scale production to full commercial supply. Their facilities manufacture monoclonal antibodies, recombinant proteins, vaccines, biosimilars, plasma-derived products, gene therapies, and cell therapies, all of which require sterile handling of process fluids across multiple manufacturing steps. Bioprocess bags are integrated into media preparation, buffer storage, cell culture, intermediate product collection, purification support, formulation, and bulk product storage, making them essential components of daily manufacturing operations. As product portfolios expand, these companies increasingly rely on flexible single-use technologies that simplify multiproduct manufacturing while minimizing contamination risks between production campaigns. Disposable bags eliminate cleaning and sterilization procedures associated with reusable process vessels, allowing manufacturers to improve operational efficiency and reduce turnaround time between batches. Many facilities also use modular manufacturing strategies where single-use systems facilitate rapid process expansion without major infrastructure investments. Regulatory expectations for product quality, traceability, and contamination control further encourage adoption of prequalified disposable assemblies supplied by specialized manufacturers. Bioprocess bags are compatible with automated process equipment, enabling standardized workflows that improve manufacturing consistency and simplify validation activities. Their availability in different capacities allows companies to support early-stage clinical production as well as commercial-scale operations using similar technologies. In addition, continuous investment in biologics research and manufacturing innovation has increased demand for flexible production platforms capable of accommodating diverse therapeutic products.

to Download this information in a PDF

Bioprocess Bags Market Regional Insights

North America is the largest regional market because it has a highly established biopharmaceutical manufacturing ecosystem supported by advanced production facilities, strong technology adoption, and extensive biologics research activities. North America occupies a leading position in the global bioprocess bags market because the region hosts one of the world's most mature biopharmaceutical industries, characterized by large-scale commercial manufacturing, continuous research activity, and widespread implementation of advanced production technologies. The United States and Canada contain numerous biologics manufacturing facilities producing monoclonal antibodies, recombinant proteins, vaccines, plasma-derived therapies, cell therapies, and gene therapies, all of which require sterile fluid handling throughout manufacturing. The region has been an early adopter of single-use bioprocessing technologies, encouraging extensive integration of disposable bioprocess bags into upstream, downstream, and fill-finish operations. Strong collaboration between biotechnology companies, pharmaceutical manufacturers, academic research institutions, and technology suppliers has accelerated innovation in manufacturing processes and increased demand for high-performance disposable systems. Regulatory agencies maintain rigorous expectations regarding product quality, contamination prevention, and process consistency, reinforcing the use of closed-system technologies that support aseptic manufacturing. North America also contains many global suppliers of bioprocess equipment, single-use assemblies, and specialized polymer films, creating a well-developed supply chain that supports reliable product availability and continuous technological improvement. • USA: The United States leads the North American bioprocess bags market because it has the region’s most extensive biopharmaceutical manufacturing infrastructure and the highest concentration of biologics production facilities. The country hosts a large network of manufacturing plants dedicated to monoclonal antibodies, recombinant proteins, vaccines, cell therapies, gene therapies, and biosimilars, all of which rely heavily on sterile single-use technologies.

to Download this information in a PDF

Key Development

• March 2026: Repligen Corporation launched the CTech SoloVPE PLUS System, expanding its process analytical technology portfolio for biopharmaceutical manufacturing with enhanced UV-based concentration measurement capabilities that complement single-use bioprocessing workflows. • January 2026: Sartorius expanded its single-use bioprocessing portfolio with new scalable solutions designed to improve upstream biomanufacturing efficiency and support flexible biologics production across commercial manufacturing facilities. • November 2025: Merck KGaA (MilliporeSigma) expanded its single-use manufacturing capabilities by strengthening production capacity for bioprocessing consumables, including bioprocess bags and fluid management systems, to address rising global biologics demand. • October 2025: Thermo Fisher Scientific expanded its single-use technologies manufacturing operations to increase the production of bioprocess containers and related consumables for biopharmaceutical customers. • June 2025: Sartorius Stedim Biotech expanded manufacturing and R&D capacities for innovative bioprocess solutions in France. • May 2025: Qosina and Sealed Air launched NEXCEL BIO1250, a co-extruded bioprocessing bag film targeting high-performance single-use workflows. • May 2025: Thermo Fisher Scientific, a leading biotechnology product development and manufacturing company, received FDA approval for its new line of HyPerForm™ XL Bioprocess Bags. • March 2025: EMD Millipore, a Merck KGaA company, secured a significant investment of €150 million from Merck KGaA to expand its production capacity for single-use bioprocessing solutions, including bioprocess bags. • November 2024: Sartorius AG, a global leader in laboratory and production manufacturing, entered into a strategic partnership with Bio-Techne Corporation to expand its single-use bioprocessing portfolio. • September 2024: MilliporeSigma, the life sciences branch of Merck, introduced a single-use reactor for the production of antibody drug conjugates • August 2024: Pall Corporation, a leading life sciences and technology company, announced the launch of its new line of Next-Flow™ XS Bioprocess Bags, designed for single-use bioreactors. • April 2024: SaniSure launched Fill4Sure, a custom single-use filling assembly, to expedite drugs to market and build security, efficiency, and repeatability in drug product filling.

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Companies Mentioned

Parker Hannifin Corp (Parker Lord)
Corning Incorporated
Lonza Group AG
Danaher Corporation
DCL Corporation
Thermo Fisher Scientific Inc
Sartorius AG
Meissner Filtration Products Inc.
Tofflon Science and Technology Group Co., Ltd.
Entegris, Inc.
PBS Biotech Inc.
GEA Group AG
Saint-Gobain Bioprocess Solutions
Broadley-James Corporation
CellGenix GmbH
Kuhner AG
LePure Biotech
ESI Technologies
JYSS BIO

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Global Bioprocess Bags Market Outlook
6.1. Market Size By Value
6.2. Market Share By Region
6.3. Market Size and Forecast, By Geography
6.4. Market Size and Forecast, By Product Type
6.5. Market Size and Forecast, By Workflow
6.6. Market Size and Forecast, By End-User
7. North America Bioprocess Bags Market Outlook
7.1. Market Size By Value
7.2. Market Share By Country
7.3. Market Size and Forecast, By Product Type
7.4. Market Size and Forecast, By Workflow
7.5. Market Size and Forecast, By End-User
7.6. United States Bioprocess Bags Market Outlook
7.6.1. Market Size by Value
7.6.2. Market Size and Forecast By Product Type
7.6.3. Market Size and Forecast By Workflow
7.6.4. Market Size and Forecast By End-User
7.7. Canada Bioprocess Bags Market Outlook
7.7.1. Market Size by Value
7.7.2. Market Size and Forecast By Product Type
7.7.3. Market Size and Forecast By Workflow
7.7.4. Market Size and Forecast By End-User
7.8. Mexico Bioprocess Bags Market Outlook
7.8.1. Market Size by Value
7.8.2. Market Size and Forecast By Product Type
7.8.3. Market Size and Forecast By Workflow
7.8.4. Market Size and Forecast By End-User
8. Europe Bioprocess Bags Market Outlook
8.1. Market Size By Value
8.2. Market Share By Country
8.3. Market Size and Forecast, By Product Type
8.4. Market Size and Forecast, By Workflow
8.5. Market Size and Forecast, By End-User
8.6. Germany Bioprocess Bags Market Outlook
8.6.1. Market Size by Value
8.6.2. Market Size and Forecast By Product Type
8.6.3. Market Size and Forecast By Workflow
8.6.4. Market Size and Forecast By End-User
8.7. United Kingdom (UK) Bioprocess Bags Market Outlook
8.7.1. Market Size by Value
8.7.2. Market Size and Forecast By Product Type
8.7.3. Market Size and Forecast By Workflow
8.7.4. Market Size and Forecast By End-User
8.8. France Bioprocess Bags Market Outlook
8.8.1. Market Size by Value
8.8.2. Market Size and Forecast By Product Type
8.8.3. Market Size and Forecast By Workflow
8.8.4. Market Size and Forecast By End-User
8.9. Italy Bioprocess Bags Market Outlook
8.9.1. Market Size by Value
8.9.2. Market Size and Forecast By Product Type
8.9.3. Market Size and Forecast By Workflow
8.9.4. Market Size and Forecast By End-User
8.10. Spain Bioprocess Bags Market Outlook
8.10.1. Market Size by Value
8.10.2. Market Size and Forecast By Product Type
8.10.3. Market Size and Forecast By Workflow
8.10.4. Market Size and Forecast By End-User
8.11. Russia Bioprocess Bags Market Outlook
8.11.1. Market Size by Value
8.11.2. Market Size and Forecast By Product Type
8.11.3. Market Size and Forecast By Workflow
8.11.4. Market Size and Forecast By End-User
9. Asia-Pacific Bioprocess Bags Market Outlook
9.1. Market Size By Value
9.2. Market Share By Country
9.3. Market Size and Forecast, By Product Type
9.4. Market Size and Forecast, By Workflow
9.5. Market Size and Forecast, By End-User
9.6. China Bioprocess Bags Market Outlook
9.6.1. Market Size by Value
9.6.2. Market Size and Forecast By Product Type
9.6.3. Market Size and Forecast By Workflow
9.6.4. Market Size and Forecast By End-User
9.7. Japan Bioprocess Bags Market Outlook
9.7.1. Market Size by Value
9.7.2. Market Size and Forecast By Product Type
9.7.3. Market Size and Forecast By Workflow
9.7.4. Market Size and Forecast By End-User
9.8. India Bioprocess Bags Market Outlook
9.8.1. Market Size by Value
9.8.2. Market Size and Forecast By Product Type
9.8.3. Market Size and Forecast By Workflow
9.8.4. Market Size and Forecast By End-User
9.9. Australia Bioprocess Bags Market Outlook
9.9.1. Market Size by Value
9.9.2. Market Size and Forecast By Product Type
9.9.3. Market Size and Forecast By Workflow
9.9.4. Market Size and Forecast By End-User
9.10. South Korea Bioprocess Bags Market Outlook
9.10.1. Market Size by Value
9.10.2. Market Size and Forecast By Product Type
9.10.3. Market Size and Forecast By Workflow
9.10.4. Market Size and Forecast By End-User
10. South America Bioprocess Bags Market Outlook
10.1. Market Size By Value
10.2. Market Share By Country
10.3. Market Size and Forecast, By Product Type
10.4. Market Size and Forecast, By Workflow
10.5. Market Size and Forecast, By End-User
10.6. Brazil Bioprocess Bags Market Outlook
10.6.1. Market Size by Value
10.6.2. Market Size and Forecast By Product Type
10.6.3. Market Size and Forecast By Workflow
10.6.4. Market Size and Forecast By End-User
10.7. Argentina Bioprocess Bags Market Outlook
10.7.1. Market Size by Value
10.7.2. Market Size and Forecast By Product Type
10.7.3. Market Size and Forecast By Workflow
10.7.4. Market Size and Forecast By End-User
10.8. Colombia Bioprocess Bags Market Outlook
10.8.1. Market Size by Value
10.8.2. Market Size and Forecast By Product Type
10.8.3. Market Size and Forecast By Workflow
10.8.4. Market Size and Forecast By End-User
11. Middle East & Africa Bioprocess Bags Market Outlook
11.1. Market Size By Value
11.2. Market Share By Country
11.3. Market Size and Forecast, By Product Type
11.4. Market Size and Forecast, By Workflow
11.5. Market Size and Forecast, By End-User
11.6. United Arab Emirates (UAE) Bioprocess Bags Market Outlook
11.6.1. Market Size by Value
11.6.2. Market Size and Forecast By Product Type
11.6.3. Market Size and Forecast By Workflow
11.6.4. Market Size and Forecast By End-User
11.7. Saudi Arabia Bioprocess Bags Market Outlook
11.7.1. Market Size by Value
11.7.2. Market Size and Forecast By Product Type
11.7.3. Market Size and Forecast By Workflow
11.7.4. Market Size and Forecast By End-User
11.8. South Africa Bioprocess Bags Market Outlook
11.8.1. Market Size by Value
11.8.2. Market Size and Forecast By Product Type
11.8.3. Market Size and Forecast By Workflow
11.8.4. Market Size and Forecast By End-User
12. Competitive Landscape
12.1. Competitive Dashboard
12.2. Business Strategies Adopted by Key Players
12.3. Key Players Market Share Insights and Analysis, 2025
12.4. Key Players Market Positioning Matrix
12.5. Porter's Five Forces
12.6. Company Profile
12.6.1. Thermo Fisher Scientific Inc.
12.6.1.1. Company Snapshot
12.6.1.2. Company Overview
12.6.1.3. Financial Highlights
12.6.1.4. Geographic Insights
12.6.1.5. Business Segment & Performance
12.6.1.6. Product Portfolio
12.6.1.7. Key Executives
12.6.1.8. Strategic Moves & Developments
12.6.2. Sartorius AG
12.6.3. Danaher Corporation
12.6.4. Saint-Gobain
12.6.5. GE Healthcare
12.6.6. Merck KGaA
12.6.7. Corning Incorporated
12.6.8. Broadley-James Corporation
12.6.9. GEA Group AG
12.6.10. Parker Hannifin Corporation
12.6.11. Lonza Group AG
12.6.12. Entegris
12.6.13. Meissner Filtration Products, Inc.
12.6.14. CellGenix GmbH
12.6.15. Kuhner AG
12.6.16. Tofflon Science and Technology Group Co., Ltd.
12.6.17. LePure Biotech
12.6.18. ESI Technologies
12.6.19. JYSS BIO
12.6.20. PBS Biotech, Inc.
13. Strategic Recommendations
14. Annexure
14.1. FAQ`s
14.2. Notes
15. Disclaimer

Table 1: Global Bioprocess Bags Market Snapshot, By Segmentation (2025 & 2031F) (in USD Billion)
Table 2: Influencing Factors for Bioprocess Bags Market, 2025
Table 3: Top 10 Counties Economic Snapshot 2024
Table 4: Economic Snapshot of Other Prominent Countries 2022
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Bioprocess Bags Market Size and Forecast, By Geography (2020 to 2031F) (In USD Billion)
Table 7: Global Bioprocess Bags Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 8: Global Bioprocess Bags Market Size and Forecast, By Workflow (2020 to 2031F) (In USD Billion)
Table 9: Global Bioprocess Bags Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 10: North America Bioprocess Bags Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 11: North America Bioprocess Bags Market Size and Forecast, By Workflow (2020 to 2031F) (In USD Billion)
Table 12: North America Bioprocess Bags Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 13: United States Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 14: United States Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 15: United States Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 16: Canada Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 17: Canada Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 18: Canada Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 19: Mexico Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 20: Mexico Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 21: Mexico Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 22: Europe Bioprocess Bags Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 23: Europe Bioprocess Bags Market Size and Forecast, By Workflow (2020 to 2031F) (In USD Billion)
Table 24: Europe Bioprocess Bags Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 25: Germany Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 26: Germany Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 27: Germany Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 28: United Kingdom (UK) Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 29: United Kingdom (UK) Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 30: United Kingdom (UK) Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 31: France Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 32: France Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 33: France Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 34: Italy Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 35: Italy Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 36: Italy Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 37: Spain Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 38: Spain Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 39: Spain Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 40: Russia Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 41: Russia Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 42: Russia Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 43: Asia-Pacific Bioprocess Bags Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 44: Asia-Pacific Bioprocess Bags Market Size and Forecast, By Workflow (2020 to 2031F) (In USD Billion)
Table 45: Asia-Pacific Bioprocess Bags Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 46: China Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 47: China Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 48: China Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 49: Japan Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 50: Japan Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 51: Japan Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 52: India Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 53: India Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 54: India Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 55: Australia Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 56: Australia Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 57: Australia Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 58: South Korea Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 59: South Korea Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 60: South Korea Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 61: South America Bioprocess Bags Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 62: South America Bioprocess Bags Market Size and Forecast, By Workflow (2020 to 2031F) (In USD Billion)
Table 63: South America Bioprocess Bags Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 64: Brazil Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 65: Brazil Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 66: Brazil Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 67: Argentina Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 68: Argentina Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 69: Argentina Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 70: Colombia Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 71: Colombia Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 72: Colombia Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 73: Middle East & Africa Bioprocess Bags Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 74: Middle East & Africa Bioprocess Bags Market Size and Forecast, By Workflow (2020 to 2031F) (In USD Billion)
Table 75: Middle East & Africa Bioprocess Bags Market Size and Forecast, By End-User (2020 to 2031F) (In USD Billion)
Table 76: United Arab Emirates (UAE) Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 77: United Arab Emirates (UAE) Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 78: United Arab Emirates (UAE) Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 79: Saudi Arabia Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 80: Saudi Arabia Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 81: Saudi Arabia Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 82: South Africa Bioprocess Bags Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 83: South Africa Bioprocess Bags Market Size and Forecast By Workflow (2020 to 2031F) (In USD Billion)
Table 84: South Africa Bioprocess Bags Market Size and Forecast By End-User (2020 to 2031F) (In USD Billion)
Table 85: Competitive Dashboard of top 5 players, 2025
Table 86: Key Players Market Share Insights and Analysis for Bioprocess Bags Market 2025

Figure 1: Global Bioprocess Bags Market Size (USD Billion) By Region, 2025 & 2031F
Figure 2: Market attractiveness Index, By Region 2031F
Figure 3: Market attractiveness Index, By Segment 2031F
Figure 4: Global Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: Global Bioprocess Bags Market Share By Region (2025)
Figure 6: North America Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: North America Bioprocess Bags Market Share By Country (2025)
Figure 8: US Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 9: Canada Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 10: Mexico Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 11: Europe Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 12: Europe Bioprocess Bags Market Share By Country (2025)
Figure 13: Germany Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 14: United Kingdom (UK) Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 15: France Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 16: Italy Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 17: Spain Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 18: Russia Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 19: Asia-Pacific Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 20: Asia-Pacific Bioprocess Bags Market Share By Country (2025)
Figure 21: China Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 22: Japan Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 23: India Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 24: Australia Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 25: South Korea Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 26: South America Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 27: South America Bioprocess Bags Market Share By Country (2025)
Figure 28: Brazil Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 29: Argentina Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 30: Colombia Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 31: Middle East & Africa Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 32: Middle East & Africa Bioprocess Bags Market Share By Country (2025)
Figure 33: United Arab Emirates (UAE) Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 34: Saudi Arabia Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 35: South Africa Bioprocess Bags Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 36: Porter's Five Forces of Global Bioprocess Bags Market

Bioprocess Bags Market Research FAQs

They reduce cleaning and sterilization requirements while improving operational flexibility and minimizing contamination risks.

3D bioprocess bags are widely used because they efficiently handle large fluid volumes in commercial-scale manufacturing.

Upstream processing uses the highest volume of bioprocess bags for media preparation, cell culture, and sterile fluid handling.

Biopharmaceutical companies are the leading end users due to their extensive biologics research, development, and manufacturing activities.

North America leads because of its advanced biopharmaceutical manufacturing infrastructure, strong R&D ecosystem, and widespread adoption of single-use technologies.

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted